P. Sweny

发表

Renovascular disease is associated with low producer genotypes of the anti-inflammatory cytokine interleukin-10.

Z. Varghese, D. Wheeler, G. Hamilton, 2004, Tissue antigens.

Barbara C. Thompson, D. Wheeler, M. Jarmulowicz, 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Nephrology, dialysis and transplantation.

K. Farrington, P. Sweny, 1993, Postgraduate medical journal.

Quantity of human cytomegalovirus (CMV) DNAemia as a risk factor for CMV disease in renal allograft recipients: Relationship with donor/recipient CMV serostatus, receipt of augmented methylprednisolone and antithymocyte globulin (ATG)

C. Sabin, P. Griffiths, V. Emery, 1999, Journal of medical virology.

Measurement of glomerular filtration rate without blood sampling: validation in renal transplant patients.

P. Sweny, A. Constable, V. M. Hutchings, 1984, The British journal of radiology.

Medical management of renal transplantation

P. Sweny, 2007 .

Solid Organ Transplant Recipients Reconstitution of EBV-Specific T Cell Immunity

A. Burroughs, D. Crawford, K. Rolles, 1998 .

Hyperlipidaemia and Atherosclerosis in Chronic Dialysis Patients

Z. Varghese, D. Wheeler, J. Moorhead, 1989 .

Treatment of idiopathic membranoproliferative glomerulonephritis with mycophenolate mofetil and steroids.

M. Harber, P. Sweny, E. Kingdon, 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Severe hypertension and childhood epilepsy in a 23-year-old Caucasian woman.

G. Hamilton, P. Sweny, A. Giudiceandrea, 2000, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

Atherosclerotic renovascular disease causing renal impairment--a case for treatment.

J. Moorhead, G. Hamilton, E. Maher, 1989, Clinical nephrology.

Patients with atherosclerotic renovascular disease presenting to a renal unit: an audit of outcome.

G. Hamilton, G. Stansby, P. Sweny, 1993, Postgraduate medical journal.

Serum cholesterol falls spontaneously in nephrotic patients with progressive renal disease.

Z. Varghese, J. Moorhead, P. Sweny, 1993, Renal failure.

Cyclosporine A enhances platelet aggregation.

A. Grace, D. Mikhailidis, A. Grace, 1987, Kidney international.

THREE YEARS' EXPERIENCE OF CONTINUOUS AMBULATORY PERITONEAL DIALYSIS

Z. Varghese, M. Raftery, J. Moorhead, 1981, The Lancet.

Convulsions associated with cyclosporin A in renal transplant recipients.

P. Sweny, J. Moorhead, M. Gross, 1985, British medical journal.

PLASMA-EXCHANGE AND IMMUNOSUPPRESSION IN THE TREATMENT OF FULMINATING IMMUNE-COMPLEX CRESCENTIC NEPHRITIS

A. Rees, A. Pinching, B. Pussell, 1977, The Lancet.

Heterogeneity of HLA-DR+ cells in normal human kidney. Immunohistological and cytochemical characterisation of discrete cell populations.

G. Janossy, P. Sweny, J. Moorhead, 1983, Journal of clinical pathology.

Prospective Monitoring of Epstein-Barr Virus DNA in Adult Renal Transplant Recipients During the Early Posttransplant Period: Role of Mycophenolate Mofetil

M. Harber, Colette Smith, B. Caplin, 2009, Transplantation.

Prolonged action of a chimeric interleukin-2 receptor (CD25) monoclonal antibody used in cadaveric renal transplantation.

M. Schreier, R. Moore, J. Castaigne, 1995, Transplantation.

BK Virus Nephropathy in Renal Transplant Patients in London

R. Hilton, I. Macphee, A. Frankel, 2008, Transplantation.

Nephrotoxicity of ionic and non-ionic contrast material in digital vascular imaging and selective renal arteriography.

Z. Varghese, K. Farrington, P. Sweny, 1983, The British journal of radiology.

Wegener's granulomatosis: observations on 18 patients with severe renal disease.

A. Rees, D. Evans, A. Pinching, 1983, The Quarterly journal of medicine.

Elective conversion of patients from cyclosporine to tacrolimus for hypertrichosis.

Z. Varghese, P. Sweny, O. Fernando, 1998, Transplantation proceedings.

COMPARISON OF CONTINUOUS ARTERIOVENOUS HAEMOFILTRATION AND HAEMODIALYSIS IN ACUTE RENAL FAILURE

Z. Varghese, J. Moorhead, E. Maher, 1988, The Lancet.

Failure of sodium aurothiomalate and triethyl phosphine gold to cause renal tubular injury in rheumatoid arthritis: implications for the aetiology of gold-related nephropathy

Z. Varghese, G. Panayi, P. Sweny, 1983, Clinical Rheumatology.

HOW TO MEASURE CYCLOSPORIN

Z. Varghese, J. Moorhead, P. Sweny, 1984, The Lancet.

Hyperlipidaemia in untreated nephrotic syndrome, increased production or decreased removal?

Z. Varghese, J. Moorhead, P. Sweny, 1981, Clinica chimica acta; international journal of clinical chemistry.

INCREASED EXPRESSION OF Ia (HLA-DR) ANTIGENS IN REJECTING KIDNEYS

Z. Varghese, J. Moorhead, S. Malik, 1984, The Lancet.

Effects of low-density lipoproteins on mesangial cell growth and viability in vitro.

Z. Varghese, D. Wheeler, P. Sweny, 1990, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Conversion of stable renal allografts at one year from cyclosporin A to azathioprine: a randomized controlled study

Z. Varghese, P. Sweny, J. Moorhead, 1990, Transplant international : official journal of the European Society for Organ Transplantation.

NEPHROTOXICITY OF CYCLOSPORIN A

Z. Varghese, A. Thomson, P. Whiting, 1981, The Lancet.

Is postoperative oliguria avoidable?

P. Sweny, Oliguria Avoidable, 1991, British journal of anaesthesia.

Haemolytic‐uraemic syndrome in recipients of bone marrow transplants not treated with cyclosporin A

P. Sweny, R. Marshall, 1986, Histopathology.

Studies on long‐term T‐cell‐mediated immunity to epstein‐barr virus in immunosuppressed renal allograft recipients

G. Janossy, A. Hoffbrand, D. Crawford, 1981, International journal of cancer.

LONG-TERM T-CELL-MEDIATED IMMUNITY TO EPSTEIN-BARR VIRUS IN RENAL-ALLOGRAFT RECIPIENTS RECEIVING CYCLOSPORIN A

G. Janossy, A. Hoffbrand, D. Crawford, 1981, The Lancet.

EPSTEIN BARR VIRUS NUCLEAR ANTIGEN POSITIVE LYMPHOMA AFTER CYCLOSPORIN A TREATMENT IN PATIENT WITH RENAL ALLOGRAFT

G. Janossy, D. Crawford, P. Sweny, 1980, The Lancet.

Dietary fish oil supplements preserve renal function in renal transplant recipients with chronic vascular rejection.

Z. Varghese, D. Wheeler, D. Mikhailidis, 1989, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Controlled trial of azathioprine and cyclosporin to prevent anti-HLA antibodies due to third-party transfusion.

Z. Varghese, P. Sweny, J. Moorhead, 1988, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Tumoral calcinosis and calciphylaxis presenting in a dialysis patient.

A. Davenport, P. Sweny, E. Kingdon, 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Rhabdomyolysis and systemic infection.

K. Farrington, P. Sweny, J. Moorhead, 1983, British medical journal.

Rejection encephalopathy An acute neurological syndrome complicating renal transplantation

P. Sweny, J. Moorhead, O. Fernando, 1982, Journal of the Neurological Sciences.

SYMPTOMATIC CYTOMEGALOVIRUS INFECTION IN SEROPOSITIVE KIDNEY RECIPIENTS: REINFECTION WITH DONOR VIRUS RATHER THAN REACTIVATION OF RECIPIENT VIRUS

P. Griffiths, P. Sweny, J. Moorhead, 1988, The Lancet.

Infection in solid organ transplant recipients

P. Sweny, 1989 .

HIV Infection in a Long-Term Renal Transplant Recipient

D. Pillay, S. Squire, P. Sweny, 1995, International journal of STD & AIDS.

MALIGNANT MELANOMA IN PATIENT WITH RENAL TRANSPLANT

P. Sweny, J. Moorhead, R. Baillod, 1980, The Lancet.

Nephrology, dialysis and transplantation.

K. Farrington, P. Sweny, Ken Farrington, 1990, Postgraduate medical journal.

Gastrointestinal complications of dialysis related amyloidosis.

J. Moorhead, E. Maher, P. Sweny, 1988, BMJ.

Acyclovir in hepatitis B antigen-positive chronic liver disease: inhibition of viral replication and transient renal impairment with iv bolus administration.

Z. Varghese, S. Sherlock, H. Thomas, 1983, The Journal of antimicrobial chemotherapy.

Prospective study of human betaherpesviruses after renal transplantation: association of human herpesvirus 7 and cytomegalovirus co-infection with cytomegalovirus disease and increased rejection.

C. Sabin, P. Griffiths, V. Emery, 2000, Transplantation.

RENAL PHYSIOLOGY REVISITED: AMILORIDE

Z. Varghese, J. Moorhead, P. Sweny, 1986, The Lancet.

The effect of cyclosporin A on peripheral blood T cell subpopulations in renal allografts.

N. Tidman, P. Sweny, 1982, Clinical and experimental immunology.

A randomized, controlled trial comparing ganciclovir to ganciclovir plus foscarnet (each at half dose) for preemptive therapy of cytomegalovirus infection in transplant recipients.

C. Sabin, A. Burroughs, P. Griffiths, 2004, The Journal of infectious diseases.

Reconstitution of EBV-specific T cell immunity in solid organ transplant recipients.

A. Burroughs, H. Prentice, D. Crawford, 1998, Journal of immunology.

IN VITRO CYCLOSPORINE TOXICITY: THE EFFECT OF VERAPAMIL

Z. Varghese, P. Sweny, J. Moorhead, 1989, Transplantation.

Cyclosporin in the treatment of steroid-responsive and steroid-resistant nephrotic syndrome in adults.

Z. Varghese, J. Moorhead, E. Maher, 1988, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Phenytoin‐induced pseudolymphoma. A report of a case and review of the literature

S. Whittaker, P. Sweny, L. Ostlere, 1992, The British journal of dermatology.

CYCLOSPORIN, URIC ACID, AND THE KIDNEY

Z. Varghese, K. Leunissen, J. Moorhead, 1985, The Lancet.

Infections in solid organ transplantation

A. Burroughs, P. Sweny, 1994 .

Recurrent hyperinfestation with Strongyloides stercoralis in a renal allograft recipient.

C. Fowler, J. Levin, P. Sweny, 1982, British medical journal.

Membranous glomerulonephritis and autoimmune thyroid disease.

A. Rees, A. Weetman, D. Evans, 1981, Clinical nephrology.

Extensive human cytomegalovirus (HCMV) genomic DNA in the renal tubular epithelium early after renal transplantation: Relationship with HCMV DNAemia and long‐term graft function

P. Griffiths, M. Jarmulowicz, V. Emery, 2010, Journal of medical virology.

Prolonged immunosuppressive effect and minimal immunogenicity from chimeric (CD25) monoclonal antibody SDZ CHI 621 in renal transplantation.

J. Kovarik, P. Fauchald, P. Sweny, 1996, Transplantation proceedings.

Quantity of cytomegalovirus viruria is a major risk factor for cytomegalovirus disease after renal transplantation

C. Sabin, V. Emery, P. Sweny, 1997, Journal of medical virology.

Longitudinal analysis of cytomegalovirus load in renal transplant recipients using a quantitative polymerase chain reaction: correlation with disease.

P. Griffiths, V. Emery, J. C. Fox, 1995, The Journal of general virology.

Modelling cytomegalovirus replication patterns in the human host: factors important for pathogenesis

A. Burroughs, S. Bonhoeffer, M. Johnson, 2006, Proceedings of the Royal Society B: Biological Sciences.

Haemolytic uraemic syndrome after bone marrow transplantation: an adverse effect of total body irradiation?

H. Prentice, D. Keeling, P. Sweny, 1988, Bone marrow transplantation.

Markers of HTLV-III in patients with end stage renal failure treated by haemodialysis.

P. Griffiths, P. Sweny, J. Moorhead, 1986, British medical journal.

THE ENHANCING AND SENSITIZING EFFECTS OF DONOR BLOOD COMPONENTS, INCLUDING DENDRITIC CELLS, IN A RAT RENAL ALLOGRAFT MODEL

Z. Varghese, J. Moorhead, S. Malik, 1984, Transplantation.

Prevention of contrast-induced nephropathy in vascular patients undergoing angiography: a randomized controlled trial of intravenous N-acetylcysteine.

D. Baker, G. Hamilton, P. Sweny, 2004, Journal of vascular surgery.

Kinetics of cytomegalovirus load decrease in solid-organ transplant recipients after preemptive therapy with valganciclovir.

A. Burroughs, P. Griffiths, V. Emery, 2005, Journal of Infectious Diseases.

Haemofiltration and haemodiafiltration — theoretical and practical aspects

P. Sweny, 1991 .

Sixteen months experience with cyclosporin-A in human kidney transplantation.

Z. Varghese, K. Farrington, P. Sweny, 1981, Transplantation proceedings.

Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial

A. Davenport, A. Burroughs, P. Griffiths, 2011, The Lancet.

Functional Impairment of Cytomegalovirus Specific CD8 T Cells Predicts High‐Level Replication After Renal Transplantation

P. Klenerman, R. Phillips, V. Emery, 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Double-blind, placebo-controlled trial of human lymphoblastoid interferon prophylaxis of cytomegalovirus infection in renal transplant recipients.

P. Griffiths, P. Sweny, J. Grundy, 1992, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Digital vascular imaging and selective renin sampling in evaluation of vascular anatomy in renal transplant recipients.

Z. Varghese, K. Farrington, P. Sweny, 1983, British medical journal.

Cyclosporin-induced renal magnesium leak in renal transplant patients.

Z. Varghese, P. Sweny, J. Moorhead, 1990, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Pregnancy in renal transplant recipients: the Royal Free Hospital experience.

P. Sweny, B. Thompson, E. Kingdon, 2003, QJM : monthly journal of the Association of Physicians.

Can urinary thyroid hormone loss cause hypothyroidism?

J. Moorhead, P. Sweny, V. Fonseca, 1991, The Lancet.

Tuberculous peritonitis complicating peritoneal dialysis: a case for early diagnostic laparotomy?

P. Sweny, J. Moorhead, R. Baillod, 1992, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Optimum route of administration of vitamin D in renal failure.

P. Sweny, 1995, Nephrology, Dialysis and Transplantation.

Angiotensin converting enzyme inhibitors and renal artery occlusion.

G. Hamilton, G. Stansby, P. Sweny, 1989, BMJ.

Abdominal hernias in patients receiving continuous ambulatory peritoneal dialysis.

P. Sweny, J. Moorhead, R. Baillod, 1981, British medical journal.

Calycoureterostomy: a novel technique for post-renal transplant stricture.

G. Thevendran, P. Sweny, O. Fernando, 2004, The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland.

Patients withatherosclerotic renovascular disease presenting toarenal unit: anaudit ofoutcome

P. Sweny, J. Scoble, G. Stansbyl, 1993 .

Thepharmacokinetics ofperindopril andits effects onserum angiotensin converting enzymeactivity inhypertensive patients withchronic renal failure

P. Desché, P. Sweny, P. Genissel, 1992 .

The pharmacokinetics of perindopril and its effects on serum angiotensin converting enzyme activity in hypertensive patients with chronic renal failure.

P. Desché, P. Sweny, P. Genissel, 1992, British journal of clinical pharmacology.

Oxidizability of low-density lipoproteins from Neoral and tacrolimus-treated renal transplant patients.

A. Davenport, Z. Varghese, P. Sweny, 1998, Transplantation proceedings.

Glomerulonephritis, thymoma and myasthenia gravis.

G. Scadding, J. Newsom-Davis, S. Wilson, 1983, The Quarterly journal of medicine.

THE PROGNOSTIC SIGNIFICANCE OF POSITIVE CMV CULTURES DURING SURVEILLANCE OF RENAL TRANSPLANT RECIPIENTS

D. Pillay, P. Griffiths, P. Sweny, 1993, Transplantation.

INDUCTION OF IMMUNOLOGICAL UNRESPONSIVENESS BY MULTIPLE BLOOD TRANSFUSION IN URAEMIC PATIENTS

Z. Varghese, A. Hoffbrand, P. Sweny, 1981, The Lancet.

RENAL TRANSPLANTATION AFTER REMOVAL OF ANTI-HLA ANTIBODIES

Z. Varghese, J. Moorhead, S. Malik, 1984, The Lancet.

Pharmacokinetics and immunodynamics of chimeric IL‐2 receptor monoclonal antibody SDZ CHI 621 in renal allograft recipients

J. Kovarik, P. Fauchald, P. Sweny, 1996, Transplant international : official journal of the European Society for Organ Transplantation.

Effect of pamidronate on bone loss after kidney transplantation: a randomized trial.

M. Yaqoob, M. Hall-Craggs, P. Altmann, 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Screening for renovascular disease with captopril-enhanced renography.

E. Maher, E R Maher, P. Sweny, 1992, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Low-dose vs high-dose intravenous methylprednisolone therapy for acute renal allograft rejection in patients receiving cyclosporin therapy.

Z. Varghese, P. Sweny, J. Moorhead, 1989, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

(56) Phenytoin‐induced pseudolymphoma

P. Sweny, L. Ostlere, C. Buckley, 1991 .

Fenclofenac induced interstitial nephritis confirmed by inadvertent rechallenge.

K. Farrington, P. Sweny, J. Moorhead, 1985, British medical journal.

Prognosis of critically-ill patients with acute renal failure: APACHE II score and other predictive factors.

J. Moorhead, E. Maher, P. Sweny, 1989, The Quarterly journal of medicine.

Parathyroid hormone as a causative factor of primary non-function in renal transplants

Z. Varghese, D. Wheeler, P. Sweny, 1988, British medical journal.

Successful renal transplantation despite a positive fluorescence-activated cell sorter crossmatch following plasma exchange of donor-specific anti-HLA antibodies.

G. Janossy, S. Malik, N. Tidman, 1986, Transplantation.

How complete is a total parathyroidectomy in uraemia?

Z. Varghese, K. Farrington, P. Sweny, 1987, British medical journal.

Combination therapy with sirolimus (rapamycin) and tacrolimus (FK-506) in treatment of refractory minimal change nephropathy, a clinical case report.

S. Pal, C. Ashley, P. Sweny, 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

MINIMAL‐CHANGE GLOMERULAR NEPHRITIS: NORMAL KIDNEYS IN AN ABNORMAL ENVIRONMENT?

P. Sweny, J. Moorhead, A. Dorman, 1994, Transplantation.

The source of cytomegalovirus infection in seropositive renal allograft recipients is frequently the donor kidney.

P. Griffiths, P. Sweny, M. Super, 1987, Transplantation proceedings.

Conversion of stable renal allografts at one year from cyclosporin A to azathioprine: a randomized controlled study

Z. Varghese, P. Sweny, J. Moorhead, 1990, Transplant international : official journal of the European Society for Organ Transplantation.

Management of acute renal failure in the intensive care unit

P. Sweny, 1995 .

Effect of fluvastatin on acute renal allograft rejection: a randomized multicenter trial.

D. Wheeler, I. Holme, David Talbot, 2001, Kidney international.

REJECTION ENCEPHALOPATHY

J. Moorhead, P. Sweny, M. Gross, 1982, The Lancet.